Mobile

A trial comparing the safety and efficacy of insulin degludec and insulin glargine, both with insulin aspart as mealtime insulin in subjects with type 1 diabetes

Mise à jour : Il y a 4 ans
Référence : U1111-1129-9668

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the rates of severe or BG (blood glucose) confirmed symptomatic hypoglycaemia of IDeg once daily (OD) + IAsp to IGlar OD + IAsp, by demonstrating that the upper limit of the 95% confidence interval of the rate ratio is below or equal to a non-inferiority margin of 1.10, and if confirmed, to a superiority limit of 1.0

Critère d'inclusion

  • Diabetes Mellitus, Type 1

Liens